objective To present the current knowledge on physical function, grip strength and frailty in HIVinfected patients living in sub-Saharan Africa, where the phenomenon is largely underestimated.
Introduction
According to UNAIDS, 5.8 million people aged 50 and older were living with HIV worldwide in 2015, a phenomenon that has been increasing steadily since 1995 [1] . Sub-Saharan Africa (SSA) represents the region with the largest number of older people living with HIV (PLHIV) (3.6 million) [1] . With massive and rapid access to antiretroviral therapy (ART), the general improvement in HIV medical care services and the dramatic change in the demographics of the HIV-infected population, HIV infection can now be considered as a chronic disease almost everywhere. Older patients receiving ART are thus more and more numerous in relative and absolute terms and at an increased risk of developing age-associated non-communicable comorbidities [2, 3] .
With aging, alterations of physical function (i.e. functional limitation and disability) are more common.
Independence and social life are clearly related to physical function in older adults [4] . Functional limitation is a strong predictor of disability, hospitalisation, nursing home admission and mortality in ageing [5, 6] . In the context of HIV infection, this problem has long been neglected although up to 30% of PLHIV in Canada for instance have complaints about their physical function [7] . Recent US data show that PLHIV are affected by those impairments even at middle age [8] .
Another syndrome more frequent in aging is frailty [9] . Frail individuals present a higher risk for multiple adverse outcomes, including longer hospital stays, poorer responses to vaccination, functional decline and death [10, 11] . This syndrome is also important to consider in the context of the PLHIV aging.
As those impairments emerge as a ubiquitous public health issue, there is a risk of significant burden on the healthcare systems and human resources especially in resource-limited settings. A recent review has summarised the current knowledge about function in persons aging with HIV and living in Western countries and discussed directions for future research [12] . Our aim is to present the current knowledge on physical function, grip strength and frailty in PLHIV in SSA, reporting prevalence data and detailed risk factors when available.
Methods

Research strategy
The publications were searched on MEDLINE, Scopus and African Index Medicus using the key words used in this review, the following MeSH terms or other synonymous terms to enlarge the search and to be sure to cover all the publications on the topic: "HIV Infections" AND ("Africa" OR "Africa South of the Sahara") AND (("physical function" OR "grip strength" OR "frailty" OR "functional limitation" OR "physical performance" OR "motor activity" OR "physical activity" OR "physical activities" OR "disability" OR "disabled persons" OR "hand strength" OR "balance" OR "gait speed" OR "Activities of Daily Living"). For all, we added the filter on age "Adults: +19" (PubMed only) or the term "adults" in the search. Publications' relevance was first assessed by screening titles and abstracts. One researcher reviewed the paper contents and abstracted the data. Papers were selected based on the inclusion criteria and the definitions detailed above.
Inclusion criteria
We included cross-sectional and longitudinal studies conducted among PLHIV aged 18 years and older, living in SSA countries. We included publications written in English or French that were published up to November 2016.
When the inclusion period was available, we distinguished the pre-ART, the early ART (1996-1999) and the established ART (2000 to current) periods [13] . As the widespread availability of ART started in 2004 but did not reach high levels of saturation until recently, particularly in SSA, we added information on patients' inclusion periods, CD4 count and disease stages in the summary table when available, and details on patients' disease stage in the text. Two papers were also identified by complementary searches, and three were identified in the references of a previous systematic review [14] . Each selected article was reviewed in detail. The quality of the included studies was assessed using NIH tools available online: the Quality Assessment Tool for Observational Cohort and Cross-Sectional Studies of the NIH (https:// www.nhlbi.nih.gov/health-pro/guidelines/in-develop/card iovascular-risk-reduction/tools/cohort) and the Quality Assessment of Case-Control Studies (https://www.nhlbi. nih.gov/health-pro/guidelines/in-develop/cardiovascularrisk-reduction/tools/case-control). These two tools consist of 14 and 12 questions, respectively, assessing the quality of the papers depending on the studies' type (observational cohort/cross-sectional studies or case-control studies). For each paper included in the review, the quality was rated as good, fair or poor. When the quality was rated poor, reasons were reported. This review was conducted in accordance with the PRISMA guidelines ( Table S1 ).
Definitions of physical function
For physical function, we distinguished functional limitation and disability. According to Nagi's model, functional limitation is an important intermediate step leading to disability, which is defined as a 'limitation in performance at the level of the whole organism or person' [15] . Tests of physical performance using objective, standardised procedures are commonly used to evaluate functional limitation, with low physical performance indicating functional limitation. In the HIV literature, there is no consensus about which specific tests to use but some tests seem to be more widely used. Among the tests most commonly reported in Western countries, measurement of gait speed is evaluated over 4 or 6 m. Other tools are used for assessing leg muscle performance and balance, such as the five-time sit-to-stand test [16, 17] or the Timed Up and go test for assessing functional balance [18, 19] .
Disability can be defined as having difficulties or needing help for doing daily living activities such as self-care, instrumental and mobility tasks. Two instruments are mainly used to explore disability in two dimensions: (i) the Activities of Daily Living (ADL) instrument focuses on the ability to perform basic self-care tasks (i.e. bathing, dressing, transferring from bed to chair); and (ii) the Instrumental ADL (IADL) instrument refers to a higher level of daily living tasks (i.e. using the telephone, managing own medications, shopping, food preparation) [20] .
Definition of grip strength
Grip strength is evaluated through the force applied by the hand to pull on a dynamometer. It is an indirect measure of muscular strength. It is associated with physical function performance and disability [21] [22] [23] .
Definition of frailty
Frailty, a concept introduced by geriatricians, describes the heterogeneity of health problems occurring with age. As defined by Fried et al. in 2001, frailty is characterised by specific symptoms and/or deficits: unintentional weight loss, impaired grip strength and walking speed, fatigue and falling physical activity levels [9] . Frailty can also be viewed as a state that takes into account the cumulative effects of multiple non-specific aging health deficits [24] , but to our knowledge, there is no consensus to evaluate frailty in PLHIV.
Results
Flowchart of the selection
After a first screening to remove duplicates, 423 papers were found ( Figure 1 ). Of these, we excluded 405 papers after screening titles or abstracts (402 not on the topic and three review papers). We excluded a further two papers with no full text or abstract without sufficient information, three papers with composite scores without precise information on physical function and a paper from Tanzania that presented grip strength data from a study which targeted tuberculosis patients during their treatment, whatever their HIV status and with a large age span (15-89) [25] . Twelve papers were finally included in this systematic review (only one of them focusing on the predictors of physical function). These studies were conducted in six African countries.
Physical function
Five studies reported information on functional limitation (Table 1 part A.1). Clinical data characterizing the samples were scarcely reported. While three studies revealed no difference in gait speed between PLHIV na€ ıve or mixed (treated/untreated) and uninfected adults in Uganda [26] [27] [28] , two studies from Nigeria showed a lower gait speed among PLHIV na€ ıve or treated in comparison with those uninfected [29, 30] . No information is available on balance.
Only one study from South Africa reported information on disability (Table 1 part A.2) . This study revealed a higher incidence of disability in ART-na€ ıve PLHIV (>86%) in rural dwellers than in urban dwellers [31] . Whereas some PLHIV received first-line ART (38% rural vs. 19% urban), 27% of the patients from the rural cohort needed assistance in performing IADL at least once during the follow-up (mostly needed for cooking, cleaning, doing laundry and carrying water), vs. 3% in the urban cohort [31] .
Factors explaining the association of HIV with physical function Surprisingly, one study from Zambia reported lower performance in PLHIV on ART than in those not on ART and in uninfected adults, but this result was explained by older age in the treated group [32] . Concerning the association between ART and daily activities, in South Africa, patients on ART had 41-46% less risk of functional impairment than untreated patients [31, 33] , but the benefit seemed to be smaller in rural cohorts [31] . Another study conducted in South Africa reported that longer duration on ART, few comorbidities and high social support were associated with better physical functioning [34] . No information was available on immunosuppression, clinical stage or demographic factors.
Grip strength
Three studies reported information on grip strength (Table 1B) . In Ethiopia, adult PLHIV presented lower grip strength (À4.2 kg) at ART initiation than uninfected patients, after adjustment for age, sex, education and weight [35] . High plasma viral load, advanced WHO stages (only in men) and low body mass index (BMI) were associated with lower grip strength [35] . In a recent study, South African PLHIV aged 50 years and older had an average grip strength of 4.7 kg less than HIV-uninfected individuals without adjustment on BMI [36] . One study in Senegal reported no significant difference between PLHIV on ART and age-and sex-matched controls from the general population. However, those patients had benefited from free therapy and close medical supervision for several years (8-10) [37] .
Frailty and HIV infection
Only two studies reported information on frailty (Table 1C) . A South African large case-control study with most of the patients at an advanced HIV disease stage (72.3% WHO3/4) showed that PLHIV were more likely to be frail than HIV-uninfected individuals (19.4% vs. 13.3%); HIV infection was strongly associated with a two-fold risk of premature frailty [38] . In Senegal, a frailty prevalence of 3.5% was reported in PLHIV on ART, which was, although not statistically different, inferior to the one observed in controls (6.9%). However, those patients had benefited from free therapy and close medical supervision for several years (8-10) [37] .
Factors explaining the association of HIV with frailty
In the sole paper from SSA, low current CD4 count (<500 cells/lL) was associated with frailty among patients at advanced disease stages (72.3% WHO3/4) [38] . Lower level of education and age (OR = 2.55 per 10-year age increase) were also strongly associated with frailty in PLHIV with advanced disease (72.3% WHO3/4), especially among women [38] .
Quality of evidence
The overall quality of the papers included in the review was fair. Nine papers were observational cohort or crosssectional studies. Based on the appropriate NIH Quality Assessment Tool, the quality rating was poor for four papers, fair for three papers and good for one paper (Tables S2 and S3 ). For the studies rated as poor, the quality of the studies had to be downgraded due to scarce information on sample size justification and the absence of follow-up, limiting a potential causal relationship between exposures and outcomes. The risk of selection bias could not be clearly assessed, because information on the study population was missing. Two papers were case-control studies. Based on the appropriate NIH Quality Assessment Tool, the quality rating was fair for both of them. One study's [34] quality assessment could not be assessed for lack of information due to the paper format.
Discussion
Although the impact on the healthcare systems and human resources could be important, descriptions of functional limitation, disability, grip strength and frailty associated with HIV are clearly scarce in SSA, particularly in those aged 50 years and older.
Concerning functional limitation associated with HIV in SSA, no consensus can be reached on the severity of this impairment due to conflicting results on gait speed and absence of publications on balance. In Western countries, studies exploring the association between objective physical performance measures and earlier stages of HIV infection are rare. In the established ART period, slower gait speed and lower leg muscle function have been documented in 24% and 50% of PLHIV, respectively [39] , with a decline of these functions after 2 years of followup (34% and 31%, respectively) [40] . Other studies in the US reported no consensus for slower gait speed [41, 42] . Postural balance disorders can be an early sign of central nervous system penetration of HIV but they have not yet been investigated in SSA. In Western countries, a significant instability when standing on a non-stable foot support has been documented in the pre-ART period [43] , whereas in the ART established period, low prevalence of poor balance performance was detected (<11%) with no decline after 2 years of follow-up [40] . When evaluating both gait speed and balance in the same ART period, 20% of middle-aged HIV-infected women on ART presented an impaired performance [44] . Worse physical performance seems to be associated with higher risk of falls in the ART established period [40] . As falls increase the risk of fractures, disability and hospitalisation, evaluation of the risk of falls in those patients, particularly in the older population, and determination of their predictors are needed [39, 40] . More studies in SSA are needed to characterise this phenomenon, as the longterm consequences of poor physical performance should not be underestimated. Moreover, the need to start screening for functional limitation into the standard of care for PLHIV has recently been emphasised [45] . None of this information currently exists in SSA. Only one study on disability was identified in SSA, revealing a higher prevalence of this condition in rural than urban PLHIV. In Western countries, at the beginning of ART, the prevalence of limitations seems to be higher in energy-demanding activities such as climbing stairs (43%), walking >1 block (26%) than in self-care tasks (bathing, dressing) (14%) [46] . In a survey lacking information on clinical data to be fully interpreted, a high prevalence (>80%) of ADL difficulties, physical limitation and participation restrictions (i.e. problems with social roles) was reported in PLHIV [7] . In the established ART area, some studies reported that PLHIV had more IADL complaints [47] and needed more time to perform selected daily instrumental activities [48] than uninfected adults, with a prevalence of disabling impairments in one or more daily activities estimated between 22% and 25% in those patients of whom half had an AIDS diagnosis [49] . Older PLHIV had more difficulties in performing daily activities than younger PLHIV and HIV-uninfected adults whatever their age [50, 51] and are particularly vulnerable to decline in daily functioning [51] . As many African patients still experience AIDS events, documenting properly disability in those patients should be a priority.
Lower grip strength has been observed in African PLHIV in comparison with uninfected patients, with more impairment in those patients with advanced disease. In Western countries, data on grip strength in PLHIV are scarce [52] , and show low grip strength in PLHIV in the established ART period, particularly among older patients [53, 54] . Others observed this only in immunosuppressed HIV-infected women or among those with a history of AIDS [42] . Interestingly, it seems that the decrease in strength was close to the grip strength of HIV-uninfected older individuals (60-69 years old), suggesting similarity in the decrease in strength between older PLHIV and uninfected older adults [53] . Lower grip strength is generally associated with poor outcomes (higher risk of morbidity, mortality [55] , disability [22] , functional limitation, frailty, poorer cognitive performance and depression) in older patients. These findings underlie the importance to evaluate grip strength in PLHIV living in SSA [56] .
A higher risk of frailty has been shown in South Africa in PLHIV with advanced disease. In Western countries, in the established ART period, the prevalence of frailty in PLHIV was estimated between 9% and 20% [54, [57] [58] [59] with an increase among over 50s [57] . Interestingly, in the pre-ART period, PLHIV frequently experience frailty at a much younger age than the older general population [11, 60] , up to 10 years before it is expected [61] . While some authors revealed a similar frailty pattern between PLHIV and older HIV-uninfected subjects [11] , the characteristics of HIV-associated frailty could be different, that is not characterised by sarcopenia as in aging but more by exhaustion and low physical activity level [58] . As frailty among older PLHIV is also associated with higher risk of mortality and hospitalisation [62] with a five-fold higher duration of inpatient stay [59] and, with higher risk of falls, disability and polypharmacy [63] , further studies are clearly needed to depict this in SSA beyond the single report available today.
The risk factors of functional limitation, disability, low grip strength and frailty have been scarcely investigated in SSA. In Western countries, it has been shown that age, advanced disease stage, inflammation and some comorbidities (Hepatitis C coinfection, low body mass index, cardiovascular risk factors, depression, cognitive impairment, etc.) [40, 41, 44, 46, 50, 51, [64] [65] [66] [67] are associated with functional impairment or disability in PLHIV. Factors associated with frailty, such as age, some HIVrelated clinical measures, inflammation and some comorbidities, are also summarised in a recent review [68] . Further studies are needed in SSA to identify the potential determinants and, those that could be modifiable factors, in order to propose how to integrate the management of those impairments in HIV-care guidelines in SSA [69] .
Conclusion
Functional limitation, disability, low grip strength and frailty are now part of the burden of PLHIV living in both Western and SSA countries. Those impairments seem to occur earlier in PLHIV than in HIV-uninfected subjects and are associated with poorer outcomes, such as falls, hospitalisations and mortality although this remains to be investigated in SSA. As myotoxic drugs are still commonly prescribed as first-line ART in SSA, the characteristics of those impairments could be quite different from those observed in Western countries. Moreover, despite the fairly recent widespread of ART availability in SSA, and the consequences of immunosuppression or disease stages on functional status, the few available reports did not adjust for CD4 count or disease stages.
In this context and with the new WHO recommendations for early and universal ART [69] , further studies are needed to describe in detail this problem with an initial focus on those aged 50 years and older. Efforts are needed to use standardised survey tools for allowing comparisons across countries, as discussed in Erlandson's review [12] ; furthermore, these tools should be adapted to SSA populations, particularly for ADL/IADL questions. Finally, how to screen those impairments under routine circumstances and how to integrate this in the standard of care is now a real concern for the development and strengthening of global guidelines for a holistic care approach of HIV as a chronic infection [69] .
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